0001062993-14-005338.txt : 20140904 0001062993-14-005338.hdr.sgml : 20140904 20140904093311 ACCESSION NUMBER: 0001062993-14-005338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140903 FILED AS OF DATE: 20140904 DATE AS OF CHANGE: 20140904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NET 1 UEPS TECHNOLOGIES INC CENTRAL INDEX KEY: 0001041514 STANDARD INDUSTRIAL CLASSIFICATION: FUNCTIONS RELATED TO DEPOSITORY BANKING, NEC [6099] IRS NUMBER: 980171860 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 4TH FLOOR, PRESIDENT PLACE STREET 2: CNR. JAN SMUTS & BOLTON CITY: ROSEBANK, JOHANNESBURG STATE: T3 ZIP: 00000 BUSINESS PHONE: 27 11 343 2000 MAIL ADDRESS: STREET 1: 4TH FLOOR, PRESIDENT PLACE STREET 2: CNR. JAN SMUTS & BOLTON CITY: ROSEBANK, JOHANNESBURG STATE: T3 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seabrooke Christopher Stefan CENTRAL INDEX KEY: 0001314820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31203 FILM NUMBER: 141082140 MAIL ADDRESS: STREET 1: NET 1 UEPS TECHNOLOGIES, INC. 4TH FLR STREET 2: CNR JAN SMUTS AND BOLTON ROAD CITY: ROSEBANK JOHANNESBURG STATE: T3 ZIP: 2195 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2014-09-03 0001041514 NET 1 UEPS TECHNOLOGIES INC UEPS 0001314820 Seabrooke Christopher Stefan 4 COMMERCE SQUARE 39 RIVONIA ROAD SANDHURST, SANDTON GAUTENG RSA T3 T3 2196 SOUTH AFRICA 1 0 0 0 Common Stock 2014-09-03 4 S 0 8041 12.97 D 13604 D The common stock sold includes (i) 3,034 shares which were part of an original grant of 9,104 restricted shares, which became transferable in three equal annual installments commencing August 26, 2012; (ii) 2,286 shares which were part of an original grant of 6,857 restricted shares, which became transferable in three equal annual installments commencing August 22, 2013; and (iii) 2,721 shares which were part of an original grant of 8,163 restricted shares, which became transferable in three equal annual installments commencing August 21, 2014. Sale prices for the transactions reported here range from $12.89 to $13.09. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareholders upon request. /s/Serge Belamant, Attorney-in-Fact for Christopher Seabrooke 2014-09-04